Neosil, Inc.
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- Private, Subsidiary
- Established
- 2004-01-01
- Employees
- -
- Market Cap
- -
- Website
- http://www.neosil.com
Clinical Trials
2
Active:0
Completed:1
Trial Phases
1 Phases
Phase 2:2
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (2 trials with phase data)• Click on a phase to view related trials
Phase 2
2 (100.0%)Dose-Ranging Efficacy Study of Topical NEOSH101 to Treat Male Pattern Hair Loss
Phase 2
- Conditions
- Androgenetic Alopecia
- Interventions
- Drug: tetrapeptide aldehyde proteasome inhibitor (NEOSH101)
- First Posted Date
- 2007-05-10
- Last Posted Date
- 2008-05-20
- Lead Sponsor
- Neosil, Inc.
- Target Recruit Count
- 140
- Registration Number
- NCT00471510
- Locations
- 🇩🇪
bioskin Institute for Dermatological Research and Development GmbH, Hamburg, Germany
Efficacy Study of Topical NEOSH101 to Treat Male Pattern Hair Loss
Phase 2
Completed
- Conditions
- Androgenetic Alopecia
- Interventions
- Drug: tetrapeptide aldehyde proteasome inhibitor (NEOSH101)
- First Posted Date
- 2007-01-05
- Last Posted Date
- 2008-05-20
- Lead Sponsor
- Neosil, Inc.
- Target Recruit Count
- 180
- Registration Number
- NCT00418730
- Locations
- 🇩🇪
bioskin Institute for Dermatological Research and Development GmbH, Hamburg, Germany
News
No news found